These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
410 related items for PubMed ID: 9632883
21. Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products. Fong SE, Greenwood JD, Williamson JC, Derse D, Pallansch LA, Copeland T, Rasmussen L, Mentzer A, Nagashima K, Tobin G, Gonda MA. Virology; 1997 Jul 07; 233(2):339-57. PubMed ID: 9217057 [Abstract] [Full Text] [Related]
22. Incorporation of an artificial protease and nuclease at the HIV-1 Tat binding site of trans-activation responsive RNA. Shah K, Neenhold H, Wang Z, Rana TM. Bioconjug Chem; 1996 Jul 07; 7(3):283-9. PubMed ID: 8816949 [Abstract] [Full Text] [Related]
23. Peptide models of the Tat-TAR protein-RNA interaction. Frankel AD. Protein Sci; 1992 Dec 07; 1(12):1539-42. PubMed ID: 1304886 [No Abstract] [Full Text] [Related]
24. Characterization of the solution conformations of unbound and Tat peptide-bound forms of HIV-1 TAR RNA. Long KS, Crothers DM. Biochemistry; 1999 Aug 03; 38(31):10059-69. PubMed ID: 10433713 [Abstract] [Full Text] [Related]
25. Tat is required for efficient HIV-1 reverse transcription. Harrich D, Ulich C, García-Martínez LF, Gaynor RB. EMBO J; 1997 Mar 17; 16(6):1224-35. PubMed ID: 9135139 [Abstract] [Full Text] [Related]
26. Hydrogen-bonding contacts in the major groove are required for human immunodeficiency virus type-1 tat protein recognition of TAR RNA. Hamy F, Asseline U, Grasby J, Iwai S, Pritchard C, Slim G, Butler PJ, Karn J, Gait MJ. J Mol Biol; 1993 Mar 05; 230(1):111-23. PubMed ID: 8450529 [Abstract] [Full Text] [Related]
27. HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif. Kundu M, Ansari SA, Chepenik LG, Pomerantz RJ, Khalili K, Rappaport J, Amini S. J Hum Virol; 1999 Mar 05; 2(2):72-80. PubMed ID: 10225209 [Abstract] [Full Text] [Related]
28. Controlling human immunodeficiency virus type 1 gene expression by unnatural peptides. Huq I, Ping YH, Tamilarasu N, Rana TM. Biochemistry; 1999 Apr 20; 38(16):5172-7. PubMed ID: 10213623 [Abstract] [Full Text] [Related]
30. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Kao SY, Calman AF, Luciw PA, Peterlin BM. Nature; 1994 Apr 20; 330(6147):489-93. PubMed ID: 2825027 [Abstract] [Full Text] [Related]
37. HIV trans-activation and transcription control mechanisms. Jones KA. New Biol; 1989 Nov 20; 1(2):127-35. PubMed ID: 2562218 [Abstract] [Full Text] [Related]
39. A selection system to study protein-RNA interactions: functional display of HIV-1 Tat protein on filamentous bacteriophage M13. Hoffmann S, Willbold D. Biochem Biophys Res Commun; 1997 Jun 27; 235(3):806-11. PubMed ID: 9207243 [Abstract] [Full Text] [Related]
40. Interactions of the HIV-1 Tat and RAP74 proteins with the RNA polymerase II CTD phosphatase FCP1. Abbott KL, Archambault J, Xiao H, Nguyen BD, Roeder RG, Greenblatt J, Omichinski JG, Legault P. Biochemistry; 2005 Mar 01; 44(8):2716-31. PubMed ID: 15723517 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]